Skip to main content
Top
Published in: Journal of Gastroenterology 7/2019

01-07-2019 | Hepatitis B | Original Article—Liver, Pancreas, and Biliary Tract

Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice

Authors: Ken Tsushima, Masataka Tsuge, Nobuhiko Hiraga, Takuro Uchida, Eisuke Murakami, Grace Naswa Makokha, Mio Kurihara, Motonobu Nomura, Yuichi Hiyama, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Masami Yamauchi, Hiromi Abe-Chayama, Tomokazu Kawaoka, Daiki Miki, Michio Imamura, Hiroshi Aikata, Clair Nelson Hayes, Kazuaki Chayama

Published in: Journal of Gastroenterology | Issue 7/2019

Login to get access

Abstract

Background and aims

The clinical course and responsiveness to antiviral treatments differs among hepatitis B virus (HBV) genotypes. However, the cause of these differences is unclear. In the present study, we compared mRNA expression profiles in human hepatocyte chimeric mice infected with HBV genotypes A and C.

Methods

Fifteen chimeric mice were prepared and divided into the following three groups: uninfected control mice, HBV genotype A-infected mice, and HBV genotype C-infected mice. Human hepatocytes were collected from these mouse livers and gene expression analyses were performed using next-generation RNA sequencing.

Results

Although similar pathways were influenced by HBV infection, including inflammation mediated by chemokine and cytokine signaling, p53, and integrin signaling pathways, expression levels of up-regulated genes by HBV genotype A or C infection were quite different. In HBV genotype A-infected hepatocytes, 172 genes, including KRT23 and C10orf54, were significantly more highly expressed than in HBV genotype C-infected cells, whereas 10 genes, including SPX and IER3, were expressed at significantly lower levels. Genes associated with the p53 pathway and the inflammation mediated by chemokine and cytokine signaling pathway were more highly expressed in cells with HBV genotype A infection, whereas genes associated with CCKR signaling map and oxidative stress response were more highly expressed in cells with HBV genotype C infection.

Conclusion

Several differences in gene expression with respect to HBV genotype A and C infection were detected in human hepatocytes. These differences might be associated with genotypic difference in the clinical course or responsiveness to treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ito K, Yoneda M, Sakamoto K, et al. Virological and clinical characteristics of hepatitis B virus genotype A. J Gastroenterol. 2018;53:18–26.CrossRefPubMed Ito K, Yoneda M, Sakamoto K, et al. Virological and clinical characteristics of hepatitis B virus genotype A. J Gastroenterol. 2018;53:18–26.CrossRefPubMed
2.
go back to reference Ito K, Yotsuyanagi H, Sugiyama M, et al. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan. J Gastroenterol Hepatol. 2016;31:180–9.CrossRefPubMed Ito K, Yotsuyanagi H, Sugiyama M, et al. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan. J Gastroenterol Hepatol. 2016;31:180–9.CrossRefPubMed
3.
go back to reference Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.CrossRefPubMed
4.
go back to reference Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001;7:927–33.CrossRefPubMed Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001;7:927–33.CrossRefPubMed
5.
go back to reference Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol. 2004;165:901–12.CrossRefPubMedPubMedCentral Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol. 2004;165:901–12.CrossRefPubMedPubMedCentral
6.
go back to reference Tsuge M, Hiraga N, Takaishi H, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology. 2005;42:1046–54.CrossRefPubMed Tsuge M, Hiraga N, Takaishi H, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology. 2005;42:1046–54.CrossRefPubMed
7.
go back to reference Yatsuji H, Hiraga N, Mori N, et al. Successful treatment of an entecavir-resistant hepatitis B virus variant. J Med Virol. 2007;79:1811–7.CrossRefPubMed Yatsuji H, Hiraga N, Mori N, et al. Successful treatment of an entecavir-resistant hepatitis B virus variant. J Med Virol. 2007;79:1811–7.CrossRefPubMed
8.
go back to reference Yatsuji H, Suzuki F, Sezaki H, et al. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. J Hepatol. 2008;48:923–31.CrossRefPubMed Yatsuji H, Suzuki F, Sezaki H, et al. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. J Hepatol. 2008;48:923–31.CrossRefPubMed
9.
go back to reference Tsuge M, Takahashi S, Hiraga N, et al. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice. J Infect Dis. 2011;204:224–8.CrossRefPubMed Tsuge M, Takahashi S, Hiraga N, et al. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice. J Infect Dis. 2011;204:224–8.CrossRefPubMed
10.
go back to reference Draghici S, Khatri P, Eklund AC, et al. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. 2006;22:101–9.CrossRefPubMed Draghici S, Khatri P, Eklund AC, et al. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. 2006;22:101–9.CrossRefPubMed
11.
go back to reference Irizarry RA, Warren D, Spencer F, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods. 2005;2:345–50.CrossRefPubMed Irizarry RA, Warren D, Spencer F, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods. 2005;2:345–50.CrossRefPubMed
12.
go back to reference Guo Y, Long J, He J, et al. Exome sequencing generates high quality data in non-target regions. BMC Genom. 2012;13:194.CrossRef Guo Y, Long J, He J, et al. Exome sequencing generates high quality data in non-target regions. BMC Genom. 2012;13:194.CrossRef
14.
go back to reference Hiraga N, Imamura M, Tsuge M, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. FEBS Lett. 2007;581:1983–7.CrossRefPubMed Hiraga N, Imamura M, Tsuge M, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. FEBS Lett. 2007;581:1983–7.CrossRefPubMed
15.
go back to reference Kimura T, Imamura M, Hiraga N, et al. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. J Gen Virol. 2008;89:2108–13.CrossRefPubMed Kimura T, Imamura M, Hiraga N, et al. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. J Gen Virol. 2008;89:2108–13.CrossRefPubMed
16.
go back to reference Walters KA, Joyce MA, Thompson JC, et al. Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis. Virol J. 2006;3:37.CrossRefPubMedPubMedCentral Walters KA, Joyce MA, Thompson JC, et al. Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis. Virol J. 2006;3:37.CrossRefPubMedPubMedCentral
17.
go back to reference Wieland S, Thimme R, Purcell RH, et al. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA. 2004;101:6669–74.CrossRefPubMed Wieland S, Thimme R, Purcell RH, et al. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA. 2004;101:6669–74.CrossRefPubMed
18.
go back to reference Lin CL, Kao JH. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther. 2018;48:5–14.CrossRefPubMed Lin CL, Kao JH. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther. 2018;48:5–14.CrossRefPubMed
19.
go back to reference Livingston SE, Simonetti JP, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195:5–11.CrossRefPubMed Livingston SE, Simonetti JP, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195:5–11.CrossRefPubMed
20.
go back to reference Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:1134–43.CrossRefPubMedPubMedCentral Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:1134–43.CrossRefPubMedPubMedCentral
21.
go back to reference Sugiyama M, Tanaka Y, Kurbanov F, et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology. 2009;136(652–62):e3. Sugiyama M, Tanaka Y, Kurbanov F, et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology. 2009;136(652–62):e3.
23.
go back to reference Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol. 2011;26(Suppl 1):173–9.CrossRefPubMed Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol. 2011;26(Suppl 1):173–9.CrossRefPubMed
24.
go back to reference Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84–101.CrossRefPubMed Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84–101.CrossRefPubMed
Metadata
Title
Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice
Authors
Ken Tsushima
Masataka Tsuge
Nobuhiko Hiraga
Takuro Uchida
Eisuke Murakami
Grace Naswa Makokha
Mio Kurihara
Motonobu Nomura
Yuichi Hiyama
Hatsue Fujino
Atsushi Ono
Takashi Nakahara
Masami Yamauchi
Hiromi Abe-Chayama
Tomokazu Kawaoka
Daiki Miki
Michio Imamura
Hiroshi Aikata
Clair Nelson Hayes
Kazuaki Chayama
Publication date
01-07-2019
Publisher
Springer Japan
Keyword
Hepatitis B
Published in
Journal of Gastroenterology / Issue 7/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01558-w

Other articles of this Issue 7/2019

Journal of Gastroenterology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.